Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the National Cancer Institute
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
J. Natl. Cancer Inst 2021 Jun 08;[EPub Ahead of Print], GM Dackus, K Jóźwiak, GS Sonke, E van der Wall, PJ van Diest, S Siesling, M Hauptmann, SC LinnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.